Gyros Protein Technologies Signs Distribution Agreement with Luxembourg Bio Technologies for Peptide Synthesis Reagents
(World News Science)

UPPSALA, Sweden--(BUSINESS WIRE)--Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has signed an exclusive distribution agreement with Luxembourg Bio Technologies for two of its proprietary coupling agents, PyOxim® and K-Oxyma®, and HDMA on a non-exclusive basis. Gyros Protein Technologies will sell these reagents as part of its PurePepTM brand. Under the terms of the agreement, Gyros ......